Stifel Nicolaus Downgrades ISTA Pharmaceuticals (ISTA) to Hold
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/5/2026
- Nasdaq notches record high close as investors focus on earnings
- Oil slips on rising Mideast crude exports, G7 stocks release
- Intel stock slides as TSMC explores Terafab tie-up, analyst flags share losses
- Schneider Electric to acquire PTC for $22.6 billion in all-cash deal
- Five things to watch in markets in the week ahead
Tweet
Share
E-mailGet Alerts ISTA Hot Sheet
Price: $9.09 --0%
Rating Summary:
0 Buy, 2 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 20 | New: 35
Rating Summary:
0 Buy, 2 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 20 | New: 35
Join SI Premium – FREE
Stifel Nicolaus downgraded ISTA Pharmaceuticals (NASDAQ: ISTA) from Buy to Hold.
For more ratings news on ISTA Pharmaceuticals click here and for the rating history of ISTA Pharmaceuticals click here.
Shares of ISTA Pharmaceuticals closed at $7.20 yesterday.
For more ratings news on ISTA Pharmaceuticals click here and for the rating history of ISTA Pharmaceuticals click here.
Shares of ISTA Pharmaceuticals closed at $7.20 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Goldman Sachs Downgrades Kubota Corp (6326:JP) (KUBTY) to Sell
- Barclays Downgrades PTC Inc. (PTC) to Equalweight
- ServiceNow (NOW) PT Raised to $160 at Stifel
Create E-mail Alert Related Categories
DowngradesRelated Entities
StifelSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
